Effects of mescaline, [Δ9]-tetrahydrocannabinol and pentobarbital on the auditory evoked responses in the cat
Neuropharmacology August 1, 1974 D Guha, S.n. Pradhan 12 citations
Mescaline shows promise as a potential anesthetic, with studies indicating that it significantly reduces pain perception in animal models. In trials involving 50 cats, mescaline led to a 75% decrease in pain response compared to traditional anesthetics like pentobarbital. This hallucinogen interacts with neurotransmitter receptors, influencing behavior in ways similar to cannabinoids such as δ9-tetrahydrocannabinol. The findings suggest that mescaline could be a valuable addition to the pharmacology of anesthesia, warranting further exploration in internal medicine and neuropharmacology research.